These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27614866)

  • 21. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
    Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
    Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposal of injection material used for the treatment of hepatitis C: comparison with insulin-dependent diabetes and thromboembolism.
    Causse X; D'Alteroche L; Si Ahmed SN; Giraudeau B; Metman EH;
    Gastroenterol Clin Biol; 2005 Jan; 29(1):63-8. PubMed ID: 15738897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new reusable insulin pen (ClikSTAR) in Canadian patients with type 1 and type 2 diabetes mellitus receiving insulin glargine.
    Gottesman I; Perron P; Berard L; Stewart J; Basso N; Mettimano K; Elliott T
    Diabetes Technol Ther; 2012 Oct; 14(10):926-35. PubMed ID: 22775367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
    Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
    Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Devices for insulin administration.
    Hill J
    Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents.
    Hofman PL; Lawton SA; Peart JM; Holt JA; Jefferies CA; Robinson E; Cutfield WS
    Diabet Med; 2007 Dec; 24(12):1400-5. PubMed ID: 18042081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, cross-over comparison of preference between two reusable insulin pen devices in pen-naïve adults with diabetes.
    Wong M; Abdulnabi R; Carey MA; Fu H
    Curr Med Res Opin; 2013 May; 29(5):465-73. PubMed ID: 23438454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Patient Satisfaction After Using Prefilled Insulin Pen in Real Life in Lithuania.
    Radzevičienė L; Apanavičienė DA
    J Diabetes Sci Technol; 2015 Jul; 9(4):939-40. PubMed ID: 25795640
    [No Abstract]   [Full Text] [Related]  

  • 36. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses.
    Campos C; Lajara R; Deluzio T
    Expert Opin Pharmacother; 2012 Sep; 13(13):1837-46. PubMed ID: 22873943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin injection technique, practices observed by patients and nurses].
    Kakou B; Artus B; Barcos I; Durain D; Gilbert C; Boudrot E; Laroche F; Leridon L; Mater D
    Soins; 2010 May; (745):18, 20. PubMed ID: 20509483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals.
    Bailey T; Thurman J; Niemeyer M; Schmeisl G
    Curr Med Res Opin; 2011 Oct; 27(10):2043-52. PubMed ID: 21916529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New injection recommendations for patients with diabetes.
    Frid A; Hirsch L; Gaspar R; Hicks D; Kreugel G; Liersch J; Letondeur C; Sauvanet JP; Tubiana-Rufi N; Strauss K;
    Diabetes Metab; 2010 Sep; 36 Suppl 2():S3-18. PubMed ID: 20933208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.